GNWClass I
Antisera, Cf, Influenza Virus A, B, C
21 CFR 866.3330 / Microbiology
GNW is the FDA product code for Antisera, Cf, Influenza Virus A, B, C, a class I device type, regulated under 21 CFR 866.3330. As of , FDA records hold 16 510(k) clearances under this code, the most recent dated , and 2 recalls.
Classification record
- Product code
- GNW
- Device name
- Antisera, Cf, Influenza Virus A, B, C
- Regulation
- 21 CFR 866.3330
- Device class
- Class I
- Review panel
- Microbiology
- Submission type
- 510(k) exempt
- Implant
- No
- Life sustaining or supporting
- No
- GMP exempt
- No
- Third party review eligible
- No
- Ingested clearances
- 16
- Ingested recalls
- 2
Clearances, product code GNW
By decision yearShow the numbers
| Year | Clearances |
|---|---|
| 1987 | 2 |
| 1990 | 1 |
| 1991 | 2 |
| 1994 | 2 |
| 1996 | 1 |
| 1997 | 1 |
| 1998 | 1 |
| 2000 | 1 |
| 2002 | 1 |
| 2006 | 1 |
| 2008 | 1 |
| 2009 | 2 |
Applicants with the most clearances
Product code GNW| Applicant | Clearances |
|---|---|
| Ortho-Clinical Diagnostics, Inc. | 5 |
| Dako Diagnostics, Ltd. | 2 |
| Gull Laboratories, Inc. | 2 |
| Neogenex | 2 |
| Sita, Inc. | 2 |
| Baxter Healthcare Corporation | 1 |
| Intracel Corp. | 1 |
| Light Diagnostics | 1 |
Companies listing this code with FDA
Companies whose registered establishments list this codeFIRST ARTICLE / WEEKLY
What cleared, what was recalled, and what changed in the standards. One edition a week for the people who make medical devices.
